Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sefer Elezkurtaj

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Experimental and Molecular Pathology|March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladderPaul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
Genes, Chromosomes & Cancer|September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder CarcinomasMartina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer|April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancersHenning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
The Journal of Pathology. Clinical Research|December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancerNatalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Experimental and Molecular Pathology|March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladderPaul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
Genes, Chromosomes & Cancer|September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder CarcinomasMartina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer|April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancersHenning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
The Journal of Pathology. Clinical Research|December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancerNatalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Pageof 7